Region
Featured experience
Guotai Junan merger with Haitong and concurrent placement of shares
We advised Guotai Junan Securities on the transaction, creating the largest securities company in China
Chagee $411.2 million IPO
We advised Chagee on its IPO and Nasdaq listing
Tencent €1.16 billion investment in new Ubisoft subsidiary
We are advising Tencent on the transaction
iQIYI $350 million convertible notes offering and concurrent private repurchases
We advised iQIYI on the transactions
Cutia Therapeutics HK$412.9 million IPO
We advised Cutia on its IPO and HKEX listing
TH International warrant exchange offer
A total of approximately 19,724,988 warrants were exchanged for shares
MedSci Healthcare Holdings HK$608 million IPO
We advised MedSci on its IPO and HKEX listing
ZJLD Group HK$5.3 billion IPO
We advised ZJLD on its IPO and HKEX listing
China Education Group CNY500 million CGIF-guaranteed bonds offering
The 4% bonds are due 2026
Beisen Holding HK$155 million IPO
We advised Beisen on its IPO and HKEX listing
Complete dismissal for Tencent Music Entertainment in securities class action
We secured a complete dismissal, for the second time, in a case related to TME’s 2018 IPO
Dismissal of securities action related to PRC crackdown on afterschool tutoring
We secured dismissal of the first U.S. securities class action arising from the PRC government’s ban on for-profit tutoring
Chindata Group Holdings $300 million notes offering
The high-yield notes are due 2026
CStone Pharmaceuticals HK$392.9 million placing of new shares
We advised CStone Pharmaceuticals on the placement